usfdУльтразвуковая и функциональная диагностикаUltrasound & Functional Diagnostics1607-07712408-9494Vidar Ltd.10.24835/1607-0771-2023-3-67-95usfd-10Research ArticleУльтразвуковая диагностика в акушерстве и гинекологииObstetrics and Gynecology UltrasoundУльтразвуковые маркеры хромосомных аномалий плода в 11–14 нед беременности и их значение в эпоху современных генетических исследованийUltrasound signs of fetal chromosomal abnormalities at 11–14 weeks of pregnancy and its value in the era of modern genetic testinghttps://orcid.org/0000-0002-9569-3334БулановаМ. М.BulanovaM. M.

Буланова Мария Михайловна – аспирант кафедры акушерства и гинекологии факультета фундаментальной медицины

119991 Москва, Ленинские горы, д. 1

Maria M. Bulanova – PhD student of the Department of Obstetrics and Gynecology of Faculty of Fundamental Medicine

GSP-1, Leninskie Gory, Moscow 119991

mariabulanova98@gmail.comhttps://orcid.org/0009-0003-4761-6742СмирноваД. С.SmirnovaD. S.

Смирнова Дарья Сергеевна – заведующая отделением ультразвуковой диагностики и пренатальной диагностики перинатального центра 

123423 Москва, ул. Саляма Адиля, д. 2/44

Daria S. Smirnova – Head of Ultrasound and Prenatal Diagnostics Department of the Perinatal Centre

2/44, Salyam Adil str., Moscow 123423

mariabulanova98@gmail.comhttps://orcid.org/0000-0003-1397-6208ПанинаО. Б.PaninaO. B.

Панина Ольга Борисовна – доктор мед. наук, профессор, заведующая кафедрой акушерства и гинекологии факультета фундаментальной медицины ФГБОУ ВО “Московский государственный университет имени М.В. Ломоносова”; заведующая отделом гинекологии и репродуктивной медицины Медицинского научнообразо вательного центра ФГБОУ ВО “Московский государственный университет имени М.В. Ломоносова”

119991 Москва, Ленинские горы, д. 1

119192 Москва, Ломоносовский проспект, 27, к. 10

Olga B. Panina – Doct. of Sci. (Med.), Professor, Head of the Department of Obstetrics and Gynecology of Faculty of Medicine, Lomonosov Moscow State University; Head of the Department of Gynecology and Reproductive Medicine, Medical Research and Educational Center, Lomonosov Moscow State University

GSP-1, Leninskie Gory, Moscow 119991

27-10, Lomonosovsky prospekt, 119192, Moscow

mariabulanova98@gmail.comФГБОУ ВО “Московский государственный университет имени М.В. Ломоносова”РоссияLomonosov Moscow State UniversityRussian FederationГБУЗ “Городская клиническая больница №67 имени Л.А. Ворохобова ДЗ города Москвы”РоссияL.A. Vorohobov City Clinical Hospital No. 67Russian FederationФГБОУ ВО “Московский государственный университет имени М.В. Ломоносова”; Медицинский научно-образовательный центр ФГБОУ ВО “Московский государственный университет имени М.В. Ломоносова”РоссияLomonosov Moscow State University; Medical Research and Education Center of Lomonosov Moscow State UniversityRussian Federation202313022024036795Copyright © Буланова М.М., Смирнова Д.С., Панина О.Б., 20242024Буланова М.М., Смирнова Д.С., Панина О.Б.Bulanova M.M., Smirnova D.S., Panina O.B.This work is licensed under a Creative Commons Attribution 4.0 License.https://usfd.vidar.ru/jour/article/view/10

Средний возраст женщины на момент рождения первого ребенка продолжает увеличиваться, что повышает риск хромосомных аномалий у плода. В установленном Приказом № 1130н МЗ РФ протоколе скрининга в 11–14 нед беременности оцениваются такие ультразвуковые маркеры хромосомной патологии, как толщина воротникового пространства, визуализация носовой кости, пульсационный индекс в венозном протоке, трикуспидальная регургитация, частота сердечных сокращений. Также нарастает значимость и неинвазивного пренатального тестирования (НИПТ) в ранней пренатальной диагностике наиболее распространенных хромосомных аномалий, а именно трисомий 21, 18, 13, моносомии XO. Вместе с тем многочисленные прочие нарушения кариотипа плода также можно заподозрить при УЗИ в 11–14 нед на основании выявления ряда других ультразвуковых признаков. В данной публикации нами проведен анализ лите ратуры, посвященной поиску дополнительных ультразвуковых маркеров различ ных как более, так и менее распространенных хромосомных аномалий. Рассмотрены патологические изменения, а также особенности анатомии плода и внеплодовых структур в I триместре, которые могли бы использоваться в качестве дополнительных ультразвуковых маркеров хромосомной патологии со стороны центральной нервной системы и головы, сердца и сосудов, мочевыделительной системы, органов брюшной полости, скелета плода, а также плаценты, пуповины, амниотических оболочек. Несмотря на применение НИПТ, в том числе его расширенных панелей, сохраняется необходимость в использовании УЗИ для определения маркеров более редких, но не менее значимых хромосомных патологий, таких как триплоидии, мозаичные формы трисомий, редкие аутосомные трисомии, дупликации и делеции.

A steady increase in average maternity age at the time of first childbirth lead to a higher risk of fetal chromosomal abnormalities. The Order No. 1130n of the Ministry of Health of the Russian Federation establish the screening protocol at 11–14 weeks of gestation with assessing the followed criteria of fetal chromosomal pathology: the nuchal translucency thickness, nasal bone measurement, ductus venosus pulsatility index, tricuspid regurgitation, and heart rate. The value of non-invasive prenatal testing (NIPT) in the early prenatal diagnosis of the most common chromosomal abnormalities, as the trisomies 21, 18, 13, and monosomy X is also increasing. Additionally, numerous other fetal karyotype abnormalities can also be suspected at 11–14 weeks of gestation by revealing a number of other ultrasound signs. The article presents the literature review on additional ultrasound signs of various, both more and less common, chromosomal abnormalities. Pathological signs, abnormalities of fetal anatomy and extrafetal structures in the first trimester, which could be used as additional ultrasound signs of chromosomal pathology of various organs and systems (central nervous system and head, heart and blood vessels, urinary system, abdominal organs, fetal skeleton, as well as the placenta, umbilical cord, amniotic membranes) are described in the article. Despite the use of NIPT, including its extended panels, there remains a need to use ultrasound to detect the signs of rarer, but no less significant chromosomal pathologies, such as triploidies, mosaic trisomies, rare autosomal trisomies, duplications, and deletions.

акушерство и гинекологияпренатальная диагностикаультразвуковая диагностикахромосомные аномалииНИПТпренатальный скринингультразвуковые маркерыobstetrics and gynecologyprenatal diagnosisultrasoundchromosomal abnormalitiesNIPTprenatal screeningultrasound signsReferencesAbuhamad A., Chaoui R. First Trimester Diagnosis of Fetal Abnormalities; Wolters Kluwer Health, 2017. 774 p.Abuhamad A., Chaoui R. First Trimester Diagnosis of Fetal Abnormalities; Wolters Kluwer Health, 2017. 774 p.Демографический ежегодник России 2021. М.: Стат. сб. Росстат, 2021. 258 с. The вemographic yearbook of Russia 2021. M.: Stat. sb. Rosstat, 2021. 258 p. (In Russian)The вemographic yearbook of Russia 2021. M.: Stat. sb. Rosstat, 2021. 258 p. (In Russian)Приказ Минздрава России от 20.10.2020 N 1130н “Об утверждении порядка оказания медицинской помощи по профилю «акушерство и гинеко логия»”. 2020. 615 с.Order of the Ministry of Health of the Russian Federation dated 10.20.2020 No. 1130n “On Approval Of The Procedure For Providing Medical Care In The Field of “Obstetrics and Gynecology”. 2020. 615 p. (In Russian)Santorum M., Wright D., Syngelaki A., Karagioti N., Nicolaides K.H. Accuracy of FirstTrimester Combined Test in Screening for Trisomies 21, 18 and 13. Ultrasound Obstetr. Gynecol. 2017; 49 (6): 714–720. https://doi.org/10.1002/uog.17283Santorum M., Wright D., Syngelaki A., Karagioti N., Nicolaides K.H. Accuracy of FirstTrimester Combined Test in Screening for Trisomies 21, 18 and 13. Ultrasound Obstetr. Gynecol. 2017; 49 (6): 714–720. https://doi.org/10.1002/uog.17283Nicolaides K. Screening for Fetal Aneuploidies at 11 to 13 Weeks. Prenat. Diagn. 2011; 31: 7–15. https://doi.org/10.1002/pd.2637Nicolaides K. Screening for Fetal Aneuploidies at 11 to 13 Weeks. Prenat. Diagn. 2011; 31: 7–15. https://doi.org/10.1002/pd.2637Rajs B., Nocuń A., Matyszkiewicz A., Pasternok M., Kołodziejski M., Wiercińska E., Wiecheć M. FirstTrimester Presentation of Ultrasound Findings in Trisomy 13 and Validation of Multiparameter Ultrasound-Based Risk Calculation Models to Detect Trisomy 13 in the Late First Trimester. J. Perinat. Med. 2021; 49 (3): 341–352. https://doi.org/10.1515/jpm-2020-0383Rajs B., Nocuń A., Matyszkiewicz A., Pasternok M., Kołodziejski M., Wiercińska E., Wiecheć M. FirstTrimester Presentation of Ultrasound Findings in Trisomy 13 and Validation of Multiparameter Ultrasound-Based Risk Calculation Models to Detect Trisomy 13 in the Late First Trimester. J. Perinat. Med. 2021; 49 (3): 341–352. https://doi.org/10.1515/jpm-2020-0383Wiechec M., Knafel A., Nocun A. How Effective Is Ultrasound-Based Screening for Trisomy 18 without the Addition of Biochemistry at the Time of Late First Trimester? J. Perinat. Med. 2016; 44: 149–159. https://doi.org/10.1515/jpm-2014-0384Wiechec M., Knafel A., Nocun A. How Effective Is Ultrasound-Based Screening for Trisomy 18 without the Addition of Biochemistry at the Time of Late First Trimester? J. Perinat. Med. 2016; 44: 149–159. https://doi.org/10.1515/jpm-2014-0384Takahashi Y., Nagamatsu T., Fujii T., Hashimoto A., Sayama S., Seyama T., Iriyama T., Kumasawa K., Osuga Y., Fujii T. Congenital Extracardiac Venous System Anomaly in Two Siblings with Normal Karyotype and Increased Nuchal Translucency Thickness: A Case Report. Oxf. Med. Case Rep. 2020 (6): 172–174. https://doi.org/10.1093/OMCR/OMAA034Takahashi Y., Nagamatsu T., Fujii T., Hashimoto A., Sayama S., Seyama T., Iriyama T., Kumasawa K., Osuga Y., Fujii T. Congenital Extracardiac Venous System Anomaly in Two Siblings with Normal Karyotype and Increased Nuchal Translucency Thickness: A Case Report. Oxf. Med. Case Rep. 2020 (6): 172–174. https://doi.org/10.1093/OMCR/OMAA034Stuurman K.E., van der Mespel-Brouwer M.H., Engels M.A.J., Elting M.W., Bhola S.L., MeijersHeijboer H. Isolated Increased Nuchal Translucency in First Trimester Ultrasound Scan: Diagnostic Yield of Prenatal Microarray and Outcome of Pregnancy. Front Med. (Lausanne). 2021; 8 (10): https://doi.org/10.3389/fmed.2021.737936Stuurman K.E., van der Mespel-Brouwer M.H., Engels M.A.J., Elting M.W., Bhola S.L., MeijersHeijboer H. Isolated Increased Nuchal Translucency in First Trimester Ultrasound Scan: Diagnostic Yield of Prenatal Microarray and Outcome of Pregnancy. Front Med. (Lausanne). 2021; 8 (10): https://doi.org/10.3389/fmed.2021.737936Huang L.Y., Yang Y., He P., Li D.Z. Increased First-Trimester Nuchal Translucency Associated with a Dicentric Chromosome and 9q34.3 Microdeletion Syndrome. J. Obstet. Gynaecol. (Lahore). 2017; 37 (3): 327–329. https://doi.org/10.1080/01443615.2016.1245278Huang L.Y., Yang Y., He P., Li D.Z. Increased First-Trimester Nuchal Translucency Associated with a Dicentric Chromosome and 9q34.3 Microdeletion Syndrome. J. Obstet. Gynaecol. (Lahore). 2017; 37 (3): 327–329. https://doi.org/10.1080/01443615.2016.1245278Perlman S., Sukenik-Helevy R., Odeh M., Keren Gilat E., Gilboa Y. First-Trimester Nonvisualization of the Parotid Gland and Aneuploidy in Fetuses With Increased Nuchal Translucency: A Prospective Cohort Study. J. Ultrasound Med. 2021; 40 (1): 41–47. https://doi.org/10.1002/jum.15371Perlman S., Sukenik-Helevy R., Odeh M., Keren Gilat E., Gilboa Y. First-Trimester Nonvisualization of the Parotid Gland and Aneuploidy in Fetuses With Increased Nuchal Translucency: A Prospective Cohort Study. J. Ultrasound Med. 2021; 40 (1): 41–47. https://doi.org/10.1002/jum.15371Syngelaki A., Guerra L., Ceccacci I., Efeturk T., Nicolaides K.H. Impact of Holoprosencephaly, Exomphalos, Megacystis and High NT in First Trimester Screening for Chromosomal Abnormalities. Ultrasound Obstet. Gynecol. 2017; 50 (1): 45–48. https://doi.org/10.1002/uog.17286Syngelaki A., Guerra L., Ceccacci I., Efeturk T., Nicolaides K.H. Impact of Holoprosencephaly, Exomphalos, Megacystis and High NT in First Trimester Screening for Chromosomal Abnormalities. Ultrasound Obstet. Gynecol. 2017; 50 (1): 45–48. https://doi.org/10.1002/uog.17286Wagner P., Sonek J., Hoopmann M. First-Trimester Screening for Trisomies 18 and 13, Triploidy and Turner Syndrome by Detailed Early Anomaly Scan. Ultrasound Obstet. Gynecol. 2016; 48. 446–451. https://doi.org/10.1002/uog.15829Wagner P., Sonek J., Hoopmann M. First-Trimester Screening for Trisomies 18 and 13, Triploidy and Turner Syndrome by Detailed Early Anomaly Scan. Ultrasound Obstet. Gynecol. 2016; 48. 446–451. https://doi.org/10.1002/uog.15829Scholl J., Chasen S.T. First Trimester Cystic Hygroma: Does Early Detection Matter? Prenat. Diagn. 2016; 36 (5): 432–436. https://doi.org/10.1002/pd.4799Scholl J., Chasen S.T. First Trimester Cystic Hygroma: Does Early Detection Matter? Prenat. Diagn. 2016; 36 (5): 432–436. https://doi.org/10.1002/pd.4799Sharony R., Tepper R., Fejgin M. Fetal Lateral Neck Cysts: The Significance of Associated Findings. Prenat. Diagn. 2005; 25 (6): 507–510. https://doi.org/10.1002/pd.1161Sharony R., Tepper R., Fejgin M. Fetal Lateral Neck Cysts: The Significance of Associated Findings. Prenat. Diagn. 2005; 25 (6): 507–510. https://doi.org/10.1002/pd.1161Meyberg-Solomayer G., Hamza A., Takacs Z., Leingartner A., Radosa J., Joukhadar R., JuhaszBöss I., Solomayer E.F. The Significance of Anterolateral Neck Cysts in Early Diagnosis of Fetal Malformations. Prenat. Diagn. 2016; 36 (4): 332–337. https://doi.org/10.1002/pd.4785Meyberg-Solomayer G., Hamza A., Takacs Z., Leingartner A., Radosa J., Joukhadar R., JuhaszBöss I., Solomayer E.F. The Significance of Anterolateral Neck Cysts in Early Diagnosis of Fetal Malformations. Prenat. Diagn. 2016; 36 (4): 332–337. https://doi.org/10.1002/pd.4785Halevy R.S., Mashiach Friedler J., HershkoKlement A., Biron-Shental T., Markovitch O., Tepper R. What Are the Prevalence, Characteristics and Significance of Fetal Lateral Neck Cysts Detected in an Early Anatomical Scan? Arch. Gynecol. Obstet. 2018; 298 (1): 51–58. https://doi.org/10.1007/s00404-018-4747-zHalevy R.S., Mashiach Friedler J., HershkoKlement A., Biron-Shental T., Markovitch O., Tepper R. What Are the Prevalence, Characteristics and Significance of Fetal Lateral Neck Cysts Detected in an Early Anatomical Scan? Arch. Gynecol. Obstet. 2018; 298 (1): 51–58. https://doi.org/10.1007/s00404-018-4747-zBilardo C., Chaoui R., Hyett J., Kagan K., Karim J., Papageorghiou A., Poon L., Salomon L., Syngelaki A., Nicolaides K. ISUOG Practice Guidelines (Updated): Performance of 11–14-Week Ultrasound Scan. Ultrasound Obstet. Gynecol. 2023; 61: 127–143. https://doi.org/10.1002/uog.26106Bilardo C., Chaoui R., Hyett J., Kagan K., Karim J., Papageorghiou A., Poon L., Salomon L., Syngelaki A., Nicolaides K. ISUOG Practice Guidelines (Updated): Performance of 11–14-Week Ultrasound Scan. Ultrasound Obstet. Gynecol. 2023; 61: 127–143. https://doi.org/10.1002/uog.26106Wiechec M., Knafel A., Nocun A., Wiercinska E., Ludwin A., Ludwin I. What Are the Most Common First-Trimester Ultrasound Findings in Cases of Turner Syndrome? J. Matern. Fetal Neonatal Med. 2017; 30 (13): 1632–1636. https://doi.org/10.1080/14767058.2016.1220525Wiechec M., Knafel A., Nocun A., Wiercinska E., Ludwin A., Ludwin I. What Are the Most Common First-Trimester Ultrasound Findings in Cases of Turner Syndrome? J. Matern. Fetal Neonatal Med. 2017; 30 (13): 1632–1636. https://doi.org/10.1080/14767058.2016.1220525Sparks T.N., Thao K., Lianoglou B.R., Boe N.M., Bruce K.G., Datkhaeva I., Field N.T., Fratto V.M., Jolley J., Louise C. Laurent, Anne H. Mardy, Aisling M. Murphy, Emily Ngan, Naseem Rangwala, Catherine A. M. Rottkamp, Lisa Wilson, Erica Wu, Cherry C. Uy, Priscila Valdez Lopez, and Mary E. Norton. Nonimmune Hydrops Fetalis: Identifying the Underlying Genetic Etiology. Genet. Med. 2019; 21 (6): 27–39. https://doi.org/10.1007/978-3-031-16586-3_2Sparks T.N., Thao K., Lianoglou B.R., Boe N.M., Bruce K.G., Datkhaeva I., Field N.T., Fratto V.M., Jolley J., Louise C. Laurent, Anne H. Mardy, Aisling M. Murphy, Emily Ngan, Naseem Rangwala, Catherine A. M. Rottkamp, Lisa Wilson, Erica Wu, Cherry C. Uy, Priscila Valdez Lopez, and Mary E. Norton. Nonimmune Hydrops Fetalis: Identifying the Underlying Genetic Etiology. Genet. Med. 2019; 21 (6): 27–39. https://doi.org/10.1007/978-3-031-16586-3_2Katorza E., Gat I., Duvdevani N., Meller N., Pardo N., Barzilay E., Achiron R. Fetal Brain Anomalies Detection during the First Trimester: Expanding the Scope of Antenatal Sonography. J. Matern. Fetal Neonatal Med. 2018; 31 (4): 506–512. https://doi.org/10.1080/14767058.2017.1289165Katorza E., Gat I., Duvdevani N., Meller N., Pardo N., Barzilay E., Achiron R. Fetal Brain Anomalies Detection during the First Trimester: Expanding the Scope of Antenatal Sonography. J. Matern. Fetal Neonatal Med. 2018; 31 (4): 506–512. https://doi.org/10.1080/14767058.2017.1289165Martinez-Ten P., Illescas T., Adiego B., Estevez M., Bermejo C., Wong A. E., Sepulveda W. NonVisualization of Choroid Plexus of Fourth Ventricle as First-Trimester Predictor of Posterior Fossa Anomalies and Chromosomal Defects. Ultrasound Obstet. Gynecol. 2018; 51 (2): 199–207. https://doi.org/10.1002/uog.17445Martinez-Ten P., Illescas T., Adiego B., Estevez M., Bermejo C., Wong A. E., Sepulveda W. NonVisualization of Choroid Plexus of Fourth Ventricle as First-Trimester Predictor of Posterior Fossa Anomalies and Chromosomal Defects. Ultrasound Obstet. Gynecol. 2018; 51 (2): 199–207. https://doi.org/10.1002/uog.17445Ferreira C., Rouxinol-Dias A. L., Loureiro T., Nicolaides K. Subarachnoid Space Diameter in Chromosomally Abnormal Fetuses at 11–13 Weeks’ Gestation. J. Matern. Fetal Neonatal Med. 2019; 32 (12): 2079–2083. https://doi.org/10.1080/147 67058.2018.1425833Ferreira C., Rouxinol-Dias A. L., Loureiro T., Nicolaides K. Subarachnoid Space Diameter in Chromosomally Abnormal Fetuses at 11–13 Weeks’ Gestation. J. Matern. Fetal Neonatal Med. 2019; 32 (12): 2079–2083. https://doi.org/10.1080/147 67058.2018.1425833Pauta M., Grande M., Borobio V., Illanes C., Soler A., Nogué L., Borrell A. Is Cisterna Magna Width a Useful First-Trimester Marker of Aneuploidy? Fetal Diagn. Ther. 2019. https://doi.org/10.1159/000503386Pauta M., Grande M., Borobio V., Illanes C., Soler A., Nogué L., Borrell A. Is Cisterna Magna Width a Useful First-Trimester Marker of Aneuploidy? Fetal Diagn. Ther. 2019. https://doi.org/10.1159/000503386Talantova O.E., Koltsova A.S., Tikhonov A.V, Pendina A.A., Malysheva O.V, Tarasenko O.A., Vashukova E. S., Shabanova E. S., Golubeva A.V, Chiryaeva O.G., Glotov A.S., Bespalova O.N., Efimova O.A. Prenatal Detection of Trisomy 2: Considerations for Genetic Counseling and Testing. Genes (Basel). 14 (913): 1–10. https://doi.org/10.3390/genes14040913Talantova O.E., Koltsova A.S., Tikhonov A.V, Pendina A.A., Malysheva O.V, Tarasenko O.A., Vashukova E. S., Shabanova E. S., Golubeva A.V, Chiryaeva O.G., Glotov A.S., Bespalova O.N., Efimova O.A. Prenatal Detection of Trisomy 2: Considerations for Genetic Counseling and Testing. Genes (Basel). 14 (913): 1–10. https://doi.org/10.3390/genes14040913Wiechec M., Nocun A., Matyszkiewicz A., Wiercinska E., Latała E. First Trimester Severe Ductus Venosus Flow Abnormalities in Isolation or Combination with Other Markers of Aneuploidy and Fetal Anomalies. J. Perinat. Med. 2016; 44 (2): 201–209. https://doi.org/10.1515/jpm-2014-0323Wiechec M., Nocun A., Matyszkiewicz A., Wiercinska E., Latała E. First Trimester Severe Ductus Venosus Flow Abnormalities in Isolation or Combination with Other Markers of Aneuploidy and Fetal Anomalies. J. Perinat. Med. 2016; 44 (2): 201–209. https://doi.org/10.1515/jpm-2014-0323De Robertis V., Rembouskos G., Fanelli T., Volpe G., Muto B., Volpe P. The Three-Vessel and Trachea View (3VTV) in the First Trimester of Pregnancy: An Additional Tool in Screening for Congenital Heart Defects (CHD) in an Unselected Population. Prenat. Diagn. 2017; 37 (7): 693–698. https://doi.org/10.1002/pd.5067De Robertis V., Rembouskos G., Fanelli T., Volpe G., Muto B., Volpe P. The Three-Vessel and Trachea View (3VTV) in the First Trimester of Pregnancy: An Additional Tool in Screening for Congenital Heart Defects (CHD) in an Unselected Population. Prenat. Diagn. 2017; 37 (7): 693–698. https://doi.org/10.1002/pd.5067Abuhamad A.Z., Chaoui R. A Practical Guide to Fetal Echocardiography: Normal and Abnormal Hearts. Fourth Edition; Lippincott Williams & Wilkins, 2022. 702 p.Abuhamad A.Z., Chaoui R. A Practical Guide to Fetal Echocardiography: Normal and Abnormal Hearts. Fourth Edition; Lippincott Williams & Wilkins, 2022. 702 p.Комарова И.В., Никифоренко А.А., Лукьянова Н.В., Винокурова Е.А. Ранняя пренатальная диаг ностика аномалии Эбштейна. Пренатальная диагностика. 2017; 16 (4): 364–368. https://doi.org/10.21516/2413-1458-2017-16-4-364-368Komarova I.V., Nikiforenko A.A., Lukianova N.V., Vinokurova E.A. Early prenatal diagnosis of Ebstein’s anomaly. Prenatalnaya Diagnostika = Prenatal diagnosis. 2017; 16 (4): 364–368. https://doi.org/10.21516/2413-1458-2017-16-4-364-368 (In Russian)Harris J., Francannet C., Pradat P., Robert E. The Epidemiology of Cardiovascular Defects, Part 2: A Study Based on Data from Three Large Registries of Congenital Malformations. Pediatr. Cardiol. 2003; 24: 222–235. https://doi.org/10.1007/s00246-002-9402-5Harris J., Francannet C., Pradat P., Robert E. The Epidemiology of Cardiovascular Defects, Part 2: A Study Based on Data from Three Large Registries of Congenital Malformations. Pediatr. Cardiol. 2003; 24: 222–235. https://doi.org/10.1007/s00246-002-9402-5Liao A. W., Sebire N. J., Geerts L., Cicero S., Nicolaides K. H. Megacystis at 10-14 Weeks of Gestation: Chromosomal Defects and Outcome According to Bladder Length. Ultrasound Obstet. Gynecol. 2003; 21 (4): 338–341. https://doi.org/10.1002/uog.81Liao A. W., Sebire N. J., Geerts L., Cicero S., Nicolaides K. H. Megacystis at 10-14 Weeks of Gestation: Chromosomal Defects and Outcome According to Bladder Length. Ultrasound Obstet. Gynecol. 2003; 21 (4): 338–341. https://doi.org/10.1002/uog.81Kao C., Lauzon J., Brundler M.A., Tang S., Somerset D. Perinatal Outcome and Prognostic Factors of Fetal Megacystis Diagnosed at 11–14 Week’s Gestation. Prenat. Diagn. 2021; 41 (3): 308–315. https://doi.org/10.1002/pd.5868Kao C., Lauzon J., Brundler M.A., Tang S., Somerset D. Perinatal Outcome and Prognostic Factors of Fetal Megacystis Diagnosed at 11–14 Week’s Gestation. Prenat. Diagn. 2021; 41 (3): 308–315. https://doi.org/10.1002/pd.5868Rochon M., Eddleman K. Controversial Ultrasound Findings. Obstet. Gynecol. Clin. N. Am. 2004; 31 (1): 61–99. https://doi.org/10.1016/S0889-8545(03) 00123-2Rochon M., Eddleman K. Controversial Ultrasound Findings. Obstet. Gynecol. Clin. N. Am. 2004; 31 (1): 61–99. https://doi.org/10.1016/S0889-8545(03) 00123-2Drugan A., Johnson M., Evans M. Ultrasound Screening for Fetal Chromosome Anomalies. Am. J. Med. Genet. 2000; 90 (2): 98–107. https://doi.org/10.1002/(sici)1096-8628(20000117)90: 23.0.co;2-hDrugan A., Johnson M., Evans M. Ultrasound Screening for Fetal Chromosome Anomalies. Am. J. Med. Genet. 2000; 90 (2): 98–107. https://doi.org/10.1002/(sici)1096-8628(20000117)90: 23.0.co;2-hD’Amico A., Buca D., Rizzo G., Khalil A., Silvi C., Makatsariya A., Nappi L., Liberati M., D’Antonio F. Outcome of Fetal Echogenic Bowel: A Systematic Review and Meta-Analysis. Prenat. Diagn. 2021; 41 (4): 391–399. https://doi.org/10.1002/pd.5638D’Amico A., Buca D., Rizzo G., Khalil A., Silvi C., Makatsariya A., Nappi L., Liberati M., D’Antonio F. Outcome of Fetal Echogenic Bowel: A Systematic Review and Meta-Analysis. Prenat. Diagn. 2021; 41 (4): 391–399. https://doi.org/10.1002/pd.5638Ormonde M., Carrilho B., Carneiro R., Alves F., Cohen Á., Martin A. Fetal Megacystis in the First Trimester: Comparing Management and Outcomes between Longitudinal Bladder Length Groups. J. Gynecol. Obstet. Hum. Reprod. 2023; 52 (1): 102503. https://doi.org/10.1016/j.jogoh.2022.102503Ormonde M., Carrilho B., Carneiro R., Alves F., Cohen Á., Martin A. Fetal Megacystis in the First Trimester: Comparing Management and Outcomes between Longitudinal Bladder Length Groups. J. Gynecol. Obstet. Hum. Reprod. 2023; 52 (1): 102503. https://doi.org/10.1016/j.jogoh.2022.102503Khalil A., Arnaoutoglou C., Pacilli M., Szabo A., David A. L., Pandya P. Outcome of Fetal Exomphalos Diagnosed at 11-14 Weeks of Gestation. Ultrasound Obstet. Gynecol. 2012; 39 (4): 401–406. https://doi.org/10.1002/uog.10048Khalil A., Arnaoutoglou C., Pacilli M., Szabo A., David A. L., Pandya P. Outcome of Fetal Exomphalos Diagnosed at 11-14 Weeks of Gestation. Ultrasound Obstet. Gynecol. 2012; 39 (4): 401–406. https://doi.org/10.1002/uog.10048Shi X., Tang H., Lu J., Yang X., Ding H., Wu J. Prenatal Genetic Diagnosis of Omphalocele by Karyotyping, Chromosomal Microarray Analysis and Exome Sequencing. Ann. Med. 2021; 53 (1): 1285–1291. https://doi.org/10.1080/07853890.2 021.1962966Shi X., Tang H., Lu J., Yang X., Ding H., Wu J. Prenatal Genetic Diagnosis of Omphalocele by Karyotyping, Chromosomal Microarray Analysis and Exome Sequencing. Ann. Med. 2021; 53 (1): 1285–1291. https://doi.org/10.1080/07853890.2 021.1962966Li H., Yao Y., Zhang C., Qin Y., Zeng L., Song J., Lu L., Wang W., Liu L. Prenatal Diagnosis and Outcomes in 320 Fetuses with Nasal Bone Anomalies. Front. Genet. 2023; 14 (8): 1–7. https://doi.org/10.3389/fgene.2023.1170720Li H., Yao Y., Zhang C., Qin Y., Zeng L., Song J., Lu L., Wang W., Liu L. Prenatal Diagnosis and Outcomes in 320 Fetuses with Nasal Bone Anomalies. Front. Genet. 2023; 14 (8): 1–7. https://doi.org/10.3389/fgene.2023.1170720Bakker M., Pace M., De Jong-Pleij E., Birnie E., Kagan K. O., Bilardo C. M. Prenasal Thickness, Prefrontal Space Ratio and Other Facial Profile Markers in First-Trimester Fetuses with Aneuploidies, Cleft Palate, and Micrognathia. Fetal Diagn. Ther. 2018; 43 (3): 231–240. https://doi.org/10.1159/000449099Bakker M., Pace M., De Jong-Pleij E., Birnie E., Kagan K. O., Bilardo C. M. Prenasal Thickness, Prefrontal Space Ratio and Other Facial Profile Markers in First-Trimester Fetuses with Aneuploidies, Cleft Palate, and Micrognathia. Fetal Diagn. Ther. 2018; 43 (3): 231–240. https://doi.org/10.1159/000449099Tekesin I., Graupner O. Assessment of the MaxillaMandible-Nasion Angle in Normal and Aneuploid Foetuses in the First Trimester of Pregnancy. J. Clin. Ultrasound. 2021; 49 (2): 110–116. https://doi.org/10.1002/jcu.22955Tekesin I., Graupner O. Assessment of the MaxillaMandible-Nasion Angle in Normal and Aneuploid Foetuses in the First Trimester of Pregnancy. J. Clin. Ultrasound. 2021; 49 (2): 110–116. https://doi.org/10.1002/jcu.22955Tekesin I., Graupner O. Measurement of Inferior Facial Angle and Prefrontal Space Ratio in First Trimester Fetuses with Aneuploidies: A Retrospective Study. J. Perinat. Med. 2019; 47 (9): 969–978. https://doi.org/10.1515/jpm-2019-0173Tekesin I., Graupner O. Measurement of Inferior Facial Angle and Prefrontal Space Ratio in First Trimester Fetuses with Aneuploidies: A Retrospective Study. J. Perinat. Med. 2019; 47 (9): 969–978. https://doi.org/10.1515/jpm-2019-0173Jones K., Jones M., del Campo M. Smith’s Recognizable Patterns of Human Malformation. 7 Ed.; Saunders, 2013. 1016 p.Jones K., Jones M., del Campo M. Smith’s Recognizable Patterns of Human Malformation. 7 Ed.; Saunders, 2013. 1016 p.Achter A., Hager T., Fimmers R., Gembruch U., Müller A. M. New Osseous Soft Markers for Trisomy 13, 18 and 21. Arch. Gynecol. Obstet. 2016; 294 (2): 251–259. https://doi.org/10.1007/s00404-015-3971-zAchter A., Hager T., Fimmers R., Gembruch U., Müller A. M. New Osseous Soft Markers for Trisomy 13, 18 and 21. Arch. Gynecol. Obstet. 2016; 294 (2): 251–259. https://doi.org/10.1007/s00404-015-3971-zEngelbrechtsen L., Brøndum-Nielsen K., Ekelund C. Detection of Triploidy at 11– 14 Weeks’ Gestation: A Cohort Study of 198 000 Pregnant Women. Ultrasound Obstet. Gynecol. 2013; 42: 530–535. https://doi.org/10.1002/uog.12460Engelbrechtsen L., Brøndum-Nielsen K., Ekelund C. Detection of Triploidy at 11– 14 Weeks’ Gestation: A Cohort Study of 198 000 Pregnant Women. Ultrasound Obstet. Gynecol. 2013; 42: 530–535. https://doi.org/10.1002/uog.12460Lugthart M.A., Horenblas J., Kleinrouweler E.C., Engels M., Knegt A.C., Huijsdens K., van Leeuwen E., Pajkrt E. Prenatal Sonographic Features Can Accurately Determine Parental Origin in Triploid Pregnancies. Prenat. Diagn. 2020; 40 (6): 705–714. https://doi.org/10.1002/pd.5666Lugthart M.A., Horenblas J., Kleinrouweler E.C., Engels M., Knegt A.C., Huijsdens K., van Leeuwen E., Pajkrt E. Prenatal Sonographic Features Can Accurately Determine Parental Origin in Triploid Pregnancies. Prenat. Diagn. 2020; 40 (6): 705–714. https://doi.org/10.1002/pd.5666Zalel Y., Shapiro I., Weissmann-Brenner A. Prenatal Sonographic Features of Triploidy at 12– 16 Weeks. Prenat. Diagn. 2016; 36: 650–655. https://doi.org/10.1002/pd.4834Zalel Y., Shapiro I., Weissmann-Brenner A. Prenatal Sonographic Features of Triploidy at 12– 16 Weeks. Prenat. Diagn. 2016; 36: 650–655. https://doi.org/10.1002/pd.4834Ghezzi F., Raio L., Di Naro E., Franchi M., Cromi A., Dürig P. Single and Multiple Umbilical Cord Cysts in Early Gestation: Two Different Entities. Ultrasound Obstet. Gynecol. 2003; 21 (3): 215–219. https://doi.org/10.1002/uog.68Ghezzi F., Raio L., Di Naro E., Franchi M., Cromi A., Dürig P. Single and Multiple Umbilical Cord Cysts in Early Gestation: Two Different Entities. Ultrasound Obstet. Gynecol. 2003; 21 (3): 215–219. https://doi.org/10.1002/uog.68Qian Y., Hu T., Zhang Z., Xiao L., Wang J., Hu R., Liao N., Liu Z., Wang H., Liu S. Prenatal Diagnosis with Chromosome Microarray Analysis and Pregnancy Outcomes of Fetuses with Umbilical Cord Cysts. J. Matern. Fetal Neonatal Med. 2023; 36 (1): 2203793. https://doi.org/10.1080/14767058.2023.2203793Qian Y., Hu T., Zhang Z., Xiao L., Wang J., Hu R., Liao N., Liu Z., Wang H., Liu S. Prenatal Diagnosis with Chromosome Microarray Analysis and Pregnancy Outcomes of Fetuses with Umbilical Cord Cysts. J. Matern. Fetal Neonatal Med. 2023; 36 (1): 2203793. https://doi.org/10.1080/14767058.2023.2203793Hannaford K., Reeves S., Wegner E. Umbilical Cord Cysts in the First Trimester. J. Ultrasound Med. 2013; 32 (5): 801–806. https://doi.org/10.7863/ultra.32.5.801Hannaford K., Reeves S., Wegner E. Umbilical Cord Cysts in the First Trimester. J. Ultrasound Med. 2013; 32 (5): 801–806. https://doi.org/10.7863/ultra.32.5.801Gilboa Y., Kivilevitch Z., Katorza E., Leshem Y., Borokovski T., Spira M., Achiron R. Outcomes of Fetuses with Umbilical Cord Cysts Diagnosed during Nuchal Translucency Examination. J. Ultrasound Med. 2011; 30 (11): 1547–1551. https://doi.org/10.7863/jum.2011.30.11.1547Gilboa Y., Kivilevitch Z., Katorza E., Leshem Y., Borokovski T., Spira M., Achiron R. Outcomes of Fetuses with Umbilical Cord Cysts Diagnosed during Nuchal Translucency Examination. J. Ultrasound Med. 2011; 30 (11): 1547–1551. https://doi.org/10.7863/jum.2011.30.11.1547Eggebø T. M., Dirdal H. U., VonBrandis P. Allantoid Cyst in the Umbilical Cord Diagnosed with B-Flow Ultrasound. BMJ Case Rep. 2012; bcr0320126064. https://doi.org/10.1136/bcr.03.2012.6064Eggebø T. M., Dirdal H. U., VonBrandis P. Allantoid Cyst in the Umbilical Cord Diagnosed with B-Flow Ultrasound. BMJ Case Rep. 2012; bcr0320126064. https://doi.org/10.1136/bcr.03.2012.6064Van Mieghem T., Hindryckx A., Van Calsteren K. Early Fetal Anatomy Screening: Who, What, When and Why? Curr. Opin. Obstet. Gynecol. 2015; 27 (2): 143–150. https://doi.org/10.1097/ GCO.0000000000000161Van Mieghem T., Hindryckx A., Van Calsteren K. Early Fetal Anatomy Screening: Who, What, When and Why? Curr. Opin. Obstet. Gynecol. 2015; 27 (2): 143–150. https://doi.org/10.1097/ GCO.0000000000000161Martínez-Payo C., Cabezas E., Nieto Y., Ruiz De Azúa M., García-Benasach F., Iglesias E. Detection of Single Umbilical Artery in the First Trimester Ultrasound: Its Value as a Marker of Fetal Malformation. Biomed. Res. Int. 2014; 548729. https://doi.org/10.1155/2014/548729Martínez-Payo C., Cabezas E., Nieto Y., Ruiz De Azúa M., García-Benasach F., Iglesias E. Detection of Single Umbilical Artery in the First Trimester Ultrasound: Its Value as a Marker of Fetal Malformation. Biomed. Res. Int. 2014; 548729. https://doi.org/10.1155/2014/548729Nakamura M., Oba T., Takita H., Tokunaka M., Arakaki T., Goto M., Koyano M., Hamada S., Matsuoka R., Sekizawa A. Differences in Perinatal Outcomes According to Forming Period of Single Umbilical Cord in Singleton Pregnancy. Prenat. Diagn. 2019; 39 (8): 588–594. https://doi.org/10.1002/pd.5471Nakamura M., Oba T., Takita H., Tokunaka M., Arakaki T., Goto M., Koyano M., Hamada S., Matsuoka R., Sekizawa A. Differences in Perinatal Outcomes According to Forming Period of Single Umbilical Cord in Singleton Pregnancy. Prenat. Diagn. 2019; 39 (8): 588–594. https://doi.org/10.1002/pd.5471Prodan N., Wagner P., Sonek J., Hoopmann M., Mutz A., Brucker S., Kagan K. O. First Trimester Uterine Artery Pulsatility Index Levels in Euploid and Aneuploid Pregnancies. Arch. Gynecol. Obstet. 2019; 300 (6): 1559–1564. https://doi.org/10.1007/s00404-019-05328-0Prodan N., Wagner P., Sonek J., Hoopmann M., Mutz A., Brucker S., Kagan K. O. First Trimester Uterine Artery Pulsatility Index Levels in Euploid and Aneuploid Pregnancies. Arch. Gynecol. Obstet. 2019; 300 (6): 1559–1564. https://doi.org/10.1007/s00404-019-05328-0Has R., Ibrahimoĝlu L., Ergene H., Ermis H., Başaran S. Partial Molar Appearance of the Placenta in Trisomy 13. Fetal Diagn. Ther. 2002; 17 (4): 205–208. https://doi.org/10.1159/000059371Has R., Ibrahimoĝlu L., Ergene H., Ermis H., Başaran S. Partial Molar Appearance of the Placenta in Trisomy 13. Fetal Diagn. Ther. 2002; 17 (4): 205–208. https://doi.org/10.1159/000059371Wax J.R., Blaszyk H., Jones M., Cartin A., Pinette M.G. The Chorionic Bump: Etiologic Insights from Two Pathologic Pregnancies. J. Clin. Ultrasound. 2016; 44 (7): 452–454. https://doi.org/10.1002/jcu.22370Wax J.R., Blaszyk H., Jones M., Cartin A., Pinette M.G. The Chorionic Bump: Etiologic Insights from Two Pathologic Pregnancies. J. Clin. Ultrasound. 2016; 44 (7): 452–454. https://doi.org/10.1002/jcu.22370Wax J., Cartin A., Litton C., Pinette M., Lucas F. First-Trimester Chorionic Bump--Association with Fetal Aneuploidy in a High-Risk Population. J. Clin. Ultrasound. 2017; 45 (1): 3–7. https://doi.org/10.1002/jcu.22417Wax J., Cartin A., Litton C., Pinette M., Lucas F. First-Trimester Chorionic Bump--Association with Fetal Aneuploidy in a High-Risk Population. J. Clin. Ultrasound. 2017; 45 (1): 3–7. https://doi.org/10.1002/jcu.22417Colpaert R.M., Ramseyer A.M., Luu T., Quick C.M., Frye L. T., Magann E. F. Diagnosis and Management of Placental Mesenchymal Disease. A Review of the Literature. Pediatr. Emerg. Care. 2017; 74 (10): 611–622. https://doi.org/10.1097/01.pec.0000526609.89886.37Colpaert R.M., Ramseyer A.M., Luu T., Quick C.M., Frye L. T., Magann E. F. Diagnosis and Management of Placental Mesenchymal Disease. A Review of the Literature. Pediatr. Emerg. Care. 2017; 74 (10): 611–622. https://doi.org/10.1097/01.pec.0000526609.89886.37Psarris A., Sindos M., Kourtis P., Pampanos A., Antsaklis P., Theodora M., Chondrogianni M. E., Morphopoulos G., Loutradis D., Daskalakis G. Placental Mesenchymal Dysplasia: Ultrasound Characteristics and Diagnostic Pitfalls. Ultrasound Int. Open. 2020; 6 (1): 3–4. https://doi.org/10.1055/a-1180-9571Psarris A., Sindos M., Kourtis P., Pampanos A., Antsaklis P., Theodora M., Chondrogianni M. E., Morphopoulos G., Loutradis D., Daskalakis G. Placental Mesenchymal Dysplasia: Ultrasound Characteristics and Diagnostic Pitfalls. Ultrasound Int. Open. 2020; 6 (1): 3–4. https://doi.org/10.1055/a-1180-9571Marinho M., Nogueira R., Soares C., Melo M., Godinho C., Brito C. Placental Spectrum Features between Mesenchymal Dysplasia and Partial Hydatidiform Mole Coexisting with a Live Fetus. J. Clin. Ultrasound. 2021; 49 (8): 841–846. https://doi.org/10.1002/jcu.23055Marinho M., Nogueira R., Soares C., Melo M., Godinho C., Brito C. Placental Spectrum Features between Mesenchymal Dysplasia and Partial Hydatidiform Mole Coexisting with a Live Fetus. J. Clin. Ultrasound. 2021; 49 (8): 841–846. https://doi.org/10.1002/jcu.23055Gerli S., Giordano C., Del Sordo R., Fratini D., Di Renzo G. C. Early Ultrasonographic Diagnosis of Placental Mesenchymal Dysplasia. Eur. Rev. Med. Pharmacol. Sci. 2014; 18 (17): 2419–2423.Gerli S., Giordano C., Del Sordo R., Fratini D., Di Renzo G. C. Early Ultrasonographic Diagnosis of Placental Mesenchymal Dysplasia. Eur. Rev. Med. Pharmacol. Sci. 2014; 18 (17): 2419–2423.Cohen M., Roper E., Sebire N., Stanek J., Anumba D. Placental Mesenchymal Dysplasia Associated with Fetal Aneuploidy. Prenat. Diagn. 2005; 25 (3): 187–192. https://doi.org/10.1002/pd.1103Cohen M., Roper E., Sebire N., Stanek J., Anumba D. Placental Mesenchymal Dysplasia Associated with Fetal Aneuploidy. Prenat. Diagn. 2005; 25 (3): 187–192. https://doi.org/10.1002/pd.1103Schmidt P., Hörmansdörfer C., Bosselmann S., Elsässer M., Scharf A. Is the Yolk Sac a New Marker for Chromosomal Abnormalities in Early Pregnancy? Arch. Gynecol. Obstet. 2011; 283 (Suppl. 1): 23–26. https://doi.org/10.1007/s00404-010-1696-6Schmidt P., Hörmansdörfer C., Bosselmann S., Elsässer M., Scharf A. Is the Yolk Sac a New Marker for Chromosomal Abnormalities in Early Pregnancy? Arch. Gynecol. Obstet. 2011; 283 (Suppl. 1): 23–26. https://doi.org/10.1007/s00404-010-1696-6Gersak K., Veble A., Mulla Z., Plavsic S. Association between Increased Yolk Sac Diameter and Abnormal Karyotypes. J. Perinat. Med. 2012; 40 (2): 251– 254. https://doi.org/10.1515/jpm.2011.140Gersak K., Veble A., Mulla Z., Plavsic S. Association between Increased Yolk Sac Diameter and Abnormal Karyotypes. J. Perinat. Med. 2012; 40 (2): 251– 254. https://doi.org/10.1515/jpm.2011.140Papaioannou G.K.I., Syngelaki A., Maiz N., Ross J.A., Nicolaides K.H. Sonographic Markers of Aneuploidies at 6-10 Weeks of Gestation. Early Hum. Dev. 2011; 87 (7): 453–456. https://doi.org/10.1016/j.earlhumdev.2011.01.045Papaioannou G.K.I., Syngelaki A., Maiz N., Ross J.A., Nicolaides K.H. Sonographic Markers of Aneuploidies at 6-10 Weeks of Gestation. Early Hum. Dev. 2011; 87 (7): 453–456. https://doi.org/10.1016/j.earlhumdev.2011.01.045Erol O., Erol M., Karaca M. Complete Chorioamniotic Separation and Persistence of a Yolk Sac Associated With Triploidy. J. Obstet. Gynaecol. Can. 2013; 35 (10): 914–916. https://doi.org/10.1016/S1701-2163(15)30813-6Erol O., Erol M., Karaca M. Complete Chorioamniotic Separation and Persistence of a Yolk Sac Associated With Triploidy. J. Obstet. Gynaecol. Can. 2013; 35 (10): 914–916. https://doi.org/10.1016/S1701-2163(15)30813-6Tan S., Pektai M. K., Özcan A. I., Akçay Y., Ozat M., Arslan H. Frequency of a Persistent Yolk Sac and Its Relationship with the Gestational Outcome. J. Ultrasound Med. 2012; 31 (5): 697– 702. https://doi.org/10.7863/jum.2012.31.5.697Tan S., Pektai M. K., Özcan A. I., Akçay Y., Ozat M., Arslan H. Frequency of a Persistent Yolk Sac and Its Relationship with the Gestational Outcome. J. Ultrasound Med. 2012; 31 (5): 697– 702. https://doi.org/10.7863/jum.2012.31.5.697Abboud P., Mansour G., Zejli A., Gondry J. Chorioamniotic Separation after 14 Weeks’ Gestation Associated with Trisomy 21. Ultrasound Obstet. Gynecol. 2003; 22 (1): 94–95. https://doi.org/10.1002/uog.140Abboud P., Mansour G., Zejli A., Gondry J. Chorioamniotic Separation after 14 Weeks’ Gestation Associated with Trisomy 21. Ultrasound Obstet. Gynecol. 2003; 22 (1): 94–95. https://doi.org/10.1002/uog.140Gerson K.D., Modest A.M., Hecht J.L., Young B.C. Persistent Amnion-Chorion Membrane Separation. J. Obstet. Gynaecol. Res. 2019; 45 (2): 352–357. https://doi.org/10.1111/jog.13852Gerson K.D., Modest A.M., Hecht J.L., Young B.C. Persistent Amnion-Chorion Membrane Separation. J. Obstet. Gynaecol. Res. 2019; 45 (2): 352–357. https://doi.org/10.1111/jog.13852Carmichael J.B., Liu H.P., Janik D., Hallahan T.W., Nicolaides K.H., Krantz D.A. Expanded Conventional First Trimester Screening. Prenat. Diagn. 2017; 37 (8): 802–807. https://doi.org/10.1002/pd.5090Carmichael J.B., Liu H.P., Janik D., Hallahan T.W., Nicolaides K.H., Krantz D.A. Expanded Conventional First Trimester Screening. Prenat. Diagn. 2017; 37 (8): 802–807. https://doi.org/10.1002/pd.5090Boutin A., Demers S., Gasse C., Giguère Y., Tétu A., Laforest G., Bujold E. First Trimester Screening for Fetal Aneuploidies Using Placental Growth Factor: The Great Obstetrical Syndrome (GOS) Study. J. Obstet. Gynaecol. Can. 2018; 40 (8): 1044– 1049. https://doi.org/10.1016/j.jogc.2017.11.032Boutin A., Demers S., Gasse C., Giguère Y., Tétu A., Laforest G., Bujold E. First Trimester Screening for Fetal Aneuploidies Using Placental Growth Factor: The Great Obstetrical Syndrome (GOS) Study. J. Obstet. Gynaecol. Can. 2018; 40 (8): 1044– 1049. https://doi.org/10.1016/j.jogc.2017.11.032astraia Obstetrics. https://www.nexus-astraia.com/products/astraia-software-international/ obstetricsastraia Obstetrics. https://www.nexus-astraia. com/products/astraia-software-international/ obstetricsRink B.D., Norton M.E. Screening for Fetal Aneuploidy. Semin. Perinatol. 2016; 40 (1): 35–43. https://doi.org/10.1053/j.semperi.2015.11.006Rink B.D., Norton M.E. Screening for Fetal Aneuploidy. Semin. Perinatol. 2016; 40 (1): 35–43. https://doi.org/10.1053/j.semperi.2015.11.006Lo J., Cori D., Norton M. Noninvasive Prenatal Testing. Obstet. Gynecol. Surv. 2014; 69: 89–99. https://doi.org/10.1097/OGX.0000000000000029Lo J., Cori D., Norton M. Noninvasive Prenatal Testing. Obstet. Gynecol. Surv. 2014; 69: 89–99. https://doi.org/10.1097/OGX.0000000000000029Norton M., Jacobsson B., Swamy G. Cell-Free DNA Analysis for Noninvasive Examination of Trisomy. N. Engl. J. Med. 2015; 372: 1589– 1597. https://doi.org/10.1056/NEJMoa1407349Norton M., Jacobsson B., Swamy G. Cell-Free DNA Analysis for Noninvasive Examination of Trisomy. N. Engl. J. Med. 2015; 372: 1589– 1597. https://doi.org/10.1056/NEJMoa1407349Reiff E., Little S., Dobson L., Wilkins-Haug L., Bromley B. What Is the Role of the 11- to 14-Week Ultrasound in Women with Negative Cell-Free DNA Screening for Aneuploidy? Prenat. Diagn. 2016; 36 (3): 260-265. https://doi.org/10.1002/pd.4774Reiff E., Little S., Dobson L., Wilkins-Haug L., Bromley B. What Is the Role of the 11- to 14-Week Ultrasound in Women with Negative Cell-Free DNA Screening for Aneuploidy? Prenat. Diagn. 2016; 36 (3): 260-265. https://doi.org/10.1002/pd.4774Rao R., Platt L. D. Ultrasound Screening: Status of Markers and Efficacy of Screening for Structural Abnormalities. Semin. Perinatol. 2016; 40 (1): 67–78. https://doi.org/10.1053/j.semperi.2015.11.009Rao R., Platt L. D. Ultrasound Screening: Status of Markers and Efficacy of Screening for Structural Abnormalities. Semin. Perinatol. 2016; 40 (1): 67–78. https://doi.org/10.1053/j.semperi.2015.11.009Norton M., Biggio J., Kuller J., Blackwell S. The Role of Ultrasound in Women Who Undergo Cell-Free DNA Screening. Am. J. Obstet. Gynecol. 2017; 216 (3): B2-B7. https://doi.org/10.1016/j.ajog.2017.01.005Norton M., Biggio J., Kuller J., Blackwell S. The Role of Ultrasound in Women Who Undergo Cell-Free DNA Screening. Am. J. Obstet. Gynecol. 2017; 216 (3): B2-B7. https://doi.org/10.1016/j.ajog.2017.01.005Reimers R.M., Mason-Suares H., Little S.E., Bromley B., Reiff E.S., Dobson L.J., WilkinsHaug L. When Ultrasound Anomalies Are Present: An Estimation of the Frequency of Chromosome Abnormalities Not Detected by Cell-Free DNA Aneuploidy Screens. Prenat. Diagn. 2018; 38 (4): 250–257. https://doi.org/10.1002/pd.5233Reimers R.M., Mason-Suares H., Little S.E., Bromley B., Reiff E.S., Dobson L.J., WilkinsHaug L. When Ultrasound Anomalies Are Present: An Estimation of the Frequency of Chromosome Abnormalities Not Detected by Cell-Free DNA Aneuploidy Screens. Prenat. Diagn. 2018; 38 (4): 250–257. https://doi.org/10.1002/pd.5233Kagan K. O., Sroka F., Sonek J., Abele H., Lüthgens K., Schmid M., Wagner P., Brucker S., Wallwiener D., Hoopmann M. First-Trimester Risk Assessment Based on Ultrasound and CellFree DNA vs Combined Screening: A Randomized Controlled Trial. Ultrasound Obstet. Gynecol. 2018; 51 (4): 437–444. https://doi.org/10.1002/uog.18905Kagan K. O., Sroka F., Sonek J., Abele H., Lüthgens K., Schmid M., Wagner P., Brucker S., Wallwiener D., Hoopmann M. First-Trimester Risk Assessment Based on Ultrasound and CellFree DNA vs Combined Screening: A Randomized Controlled Trial. Ultrasound Obstet. Gynecol. 2018; 51 (4): 437–444. https://doi.org/10.1002/uog.18905Kagan K.O., Maier V., Sonek J., Abele H., Lüthgens K., Schmid M., Wagner P., Hoopmann M. False-Positive Rate in First-Trimester Screening Based on Ultrasound and Cell-Free DNA versus First-Trimester Combined Screening with Additional Ultrasound Markers. Fetal Diagn. Ther. 2019; 45 (5): 317–324. https://doi.org/10.1159/000489121Kagan K.O., Maier V., Sonek J., Abele H., Lüthgens K., Schmid M., Wagner P., Hoopmann M. False-Positive Rate in First-Trimester Screening Based on Ultrasound and Cell-Free DNA versus First-Trimester Combined Screening with Additional Ultrasound Markers. Fetal Diagn. Ther. 2019; 45 (5): 317–324. https://doi.org/10.1159/000489121Tekesin I., Stuttgart P.U., Stuttgart P.U. The Value of Detailed First-Trimester Ultrasound Anomaly Scan for the Detection of Chromosomal Abnormalities. Ultraschall. Med. 2019; 40 (6): 743–748. https://doi.org/10.1055/a-0640-3148Tekesin I., Stuttgart P.U., Stuttgart P.U. The Value of Detailed First-Trimester Ultrasound Anomaly Scan for the Detection of Chromosomal Abnormalities. Ultraschall. Med. 2019; 40 (6): 743–748. https://doi.org/10.1055/a-0640-3148LeFevre N.M., Sundermeyer R.L. Fetal Aneuploidy: Screening and Diagnostic Testing. Am. Fam. Physician. 2020; 101 (8): 481-488LeFevre N.M., Sundermeyer R.L. Fetal Aneuploidy: Screening and Diagnostic Testing. Am. Fam. Physician. 2020; 101 (8): 481-488Capriglione S., Latella S., De Felice G., Filippini M., Ettore C., Ettore G., Farinelli M., Gulino F.A. First Trimester Screening for Aneuploidy: May Combined Test and Fetal DNA Work Together? J. Matern. Fetal Neonatal Med. 2022; 35 (22): 4258–4262. https://doi.org/10.1080/14767058.2 020.1849102Capriglione S., Latella S., De Felice G., Filippini M., Ettore C., Ettore G., Farinelli M., Gulino F.A. First Trimester Screening for Aneuploidy: May Combined Test and Fetal DNA Work Together? J. Matern. Fetal Neonatal Med. 2022; 35 (22): 4258–4262. https://doi.org/10.1080/14767058.2 020.1849102Wellesley D., Dolk H., Boyd P. Rare Chromosome Abnormalities, Prevalence and Prenatal Diagnosis Rates from Population-Based Congenital Anomaly Registers in Europe. Eur. J. Hum. Genet. 2012; 20 (5): 521–526. https://doi.org/10.1038/ejhg.2011.246Wellesley D., Dolk H., Boyd P. Rare Chromosome Abnormalities, Prevalence and Prenatal Diagnosis Rates from Population-Based Congenital Anomaly Registers in Europe. Eur. J. Hum. Genet. 2012; 20 (5): 521–526. https://doi.org/10.1038/ejhg.2011.246Norton M., Baer R., Wapner R. Cell-Free DNA vs Sequential Screening for the Detection of Fetal Chromosomal Abnormalities. Am. J. Obstet. Gynecol. 2016; 214 (727): e1–e6. https://doi.org/10.1016/j.ajog.2015.12.018Norton M., Baer R., Wapner R. Cell-Free DNA vs Sequential Screening for the Detection of Fetal Chromosomal Abnormalities. Am. J. Obstet. Gynecol. 2016; 214 (727): e1–e6. https://doi.org/10.1016/j.ajog.2015.12.018Persico N., Boito S., Volpe P., Ischia B., Gentile M., Ronzoni L., Robertis V. De, Fabietti I., Olivieri C., Periti E., Ficarella R., Silipigni R., Rembouskos G. Incidence of Chromosomal Abnormalities in Fetuses with First Trimester Ultrasound Anomalies and a Low-Risk Cell-Free DNA Test for Common Trisomies. Prenat. Diagn. 2020; 40 (11): 1474–1481. https://doi.org/10.1002/pd.5799Persico N., Boito S., Volpe P., Ischia B., Gentile M., Ronzoni L., Robertis V. De, Fabietti I., Olivieri C., Periti E., Ficarella R., Silipigni R., Rembouskos G. Incidence of Chromosomal Abnormalities in Fetuses with First Trimester Ultrasound Anomalies and a Low-Risk Cell-Free DNA Test for Common Trisomies. Prenat. Diagn. 2020; 40 (11): 1474–1481. https://doi.org/10.1002/pd.5799Kagan K.O., Sonek J., Kozlowski P. Antenatal Screening for Chromosomal Abnormalities. Arch. Gynecol. Obstet. 2022; 305 (4): 825–835. https://doi.org/10.1007/s00404-022-06477-5Kagan K.O., Sonek J., Kozlowski P. Antenatal Screening for Chromosomal Abnormalities. Arch. Gynecol. Obstet. 2022; 305 (4): 825–835. https://doi.org/10.1007/s00404-022-06477-5Mohan P., Lemoine J., Trotter C., Rakova I., Billings P., Peacock S., Kao C. Y., Wang Y., Xia F., Eng C. M., Benn P. Clinical Experience with NonInvasive Prenatal Screening for Single-Gene Disorders. Ultrasound Obstet. Gynecol. 2022; 59 (1): 33–39. https://doi.org/10.1002/uog.23756Mohan P., Lemoine J., Trotter C., Rakova I., Billings P., Peacock S., Kao C. Y., Wang Y., Xia F., Eng C. M., Benn P. Clinical Experience with NonInvasive Prenatal Screening for Single-Gene Disorders. Ultrasound Obstet. Gynecol. 2022; 59 (1): 33–39. https://doi.org/10.1002/uog.23756Bardi F., Bet B.B., Pajkrt E., Linskens I.H., Bekker M.N., Sistermans E.A., Bilardo C.M., Elvan-Taşpınar A. Additional Value of Advanced Ultrasonography in Pregnancies with Two Inconclusive Cell-Free DNA Draws. Prenat. Diagn. 2022; 42 (11): 1358–1367. https://doi.org/10.1002/pd.6238Bardi F., Bet B.B., Pajkrt E., Linskens I.H., Bekker M.N., Sistermans E.A., Bilardo C.M., Elvan-Taşpınar A. Additional Value of Advanced Ultrasonography in Pregnancies with Two Inconclusive Cell-Free DNA Draws. Prenat. Diagn. 2022; 42 (11): 1358–1367. https://doi.org/10.1002/pd.6238Yuan X., Yong W., Dai L., Wang W., Wu L. The Role of Non-Invasive Prenatal Testing and Ultrasound in Prenatal Screening of Fetal Chromosomal Abnormalities in Singleton: A Retrospective Study. Ann. Transl. Med. 2023; 11 (2): 111. https://doi.org/10.21037/atm-22-6343Yuan X., Yong W., Dai L., Wang W., Wu L. The Role of Non-Invasive Prenatal Testing and Ultrasound in Prenatal Screening of Fetal Chromosomal Abnormalities in Singleton: A Retrospective Study. Ann. Transl. Med. 2023; 11 (2): 111. https://doi.org/10.21037/atm-22-6343Scott F., Smet M.-E., Elhindi J., Mogra R., Sunderland L., Ferreira A., Menezes M., Meagher S., McLennan A. Late First-trimester Ultrasound Findings Can Alter Management after High-risk NIPT Result. Ultrasound Obstet. Gynecol. 2023; 62 (4): 497–503. https://doi.org/10.1002/uog.26272Scott F., Smet M.-E., Elhindi J., Mogra R., Sunderland L., Ferreira A., Menezes M., Meagher S., McLennan A. Late First-trimester Ultrasound Findings Can Alter Management after High-risk NIPT Result. Ultrasound Obstet. Gynecol. 2023; 62 (4): 497–503. https://doi.org/10.1002/uog.26272Han J., Li D.Z. Role of Late First-Trimester Ultrasound in Women with a Positive NIPT Result. Ultrasound Obstet. Gynecol. 2023; 62 (4): 611–612. https://doi.org/10.1002/uog.27470Han J., Li D.Z. Role of Late First-Trimester Ultrasound in Women with a Positive NIPT Result. Ultrasound Obstet. Gynecol. 2023; 62 (4): 611–612. https://doi.org/10.1002/uog.27470Ye C., Duan H., Liu M., Liu J., Xiang J., Yin Y., Zhou Q. The Value of Combined Detailed First Trimester Ultrasound – Biochemical Analysis for Screening Fetal Aneuploidy in the Era of Non Invasive Prenatal Testing. Arch. Gynecol. Obstet. 2023; 1–11. https://doi.org/10.1007/s00404-023-07267-3Ye C., Duan H., Liu M., Liu J., Xiang J., Yin Y., Zhou Q. The Value of Combined Detailed First Trimester Ultrasound – Biochemical Analysis for Screening Fetal Aneuploidy in the Era of Non Invasive Prenatal Testing. Arch. Gynecol. Obstet. 2023; 1–11. https://doi.org/10.1007/s00404-023-07267-3Battarbee A.N., Vora N.L., Hardisty E.E., Stamilio D.M. Cost-Effectiveness of Ultrasound before Non-Invasive Prenatal Screening for Fetal Aneuploidy. Ultrasound Obstet. Gynecol. 2023; 61 (3): 325–332. https://doi.org/10.1002/uog.26100Battarbee A.N., Vora N.L., Hardisty E.E., Stamilio D.M. Cost-Effectiveness of Ultrasound before Non-Invasive Prenatal Screening for Fetal Aneuploidy. Ultrasound Obstet. Gynecol. 2023; 61 (3): 325–332. https://doi.org/10.1002/uog.26100Lord J., McMullan D.J., Eberhardt R.Y., Rinck G., Hamilton S.J., Quinlan-Jones E., Prigmore E., Keelagher R., Best S.K., Carey G.K., Mellis R., Robart S., Berry I.R., Chandler K.E., Cilliers D., Cresswell L., Edwards S.L., Gardiner C., Henderson A., Holden S.T., Homfray T., Lester T., Lewis R.A., Newbury-Ecob R., Prescott K., Quarrell O.W., Ramsden S.C., Roberts E., Tapon D., Tooley M.J., Vasudevan P.C., Weber A.P., Wellesley D.G., Westwood P., White H., Parker M., Williams D., Jenkins L., Scott R.H., Kilby M.D., Chitty L.S., Hurles M.E., Maher E.R., Bateman M., Campbell C., Campbell J., Carey G., Cohen K., Collingwood E., Constantinou P., Delmege C., Ellis R., Evans J., Everett T., Pinto C.F., Forrester N., Fowler E., Hamilton S., Healey K., Hudson R., Lester T., Lewis R., Marton T., Mehta S., Park S. M., Rowland J., Steer J., Taylor E.J., Wilson E. Prenatal Exome Sequencing Analysis in Fetal Structural Anomalies Detected by Ultrasonography (PAGE): A Cohort Study. Lancet. 2019; 393 (10173): 747–757. https://doi.org/10.1016/S0140-6736(18)31940-8Lord J., McMullan D.J., Eberhardt R.Y., Rinck G., Hamilton S.J., Quinlan-Jones E., Prigmore E., Keelagher R., Best S.K., Carey G.K., Mellis R., Robart S., Berry I.R., Chandler K.E., Cilliers D., Cresswell L., Edwards S.L., Gardiner C., Henderson A., Holden S.T., Homfray T., Lester T., Lewis R.A., Newbury-Ecob R., Prescott K., Quarrell O.W., Ramsden S.C., Roberts E., Tapon D., Tooley M.J., Vasudevan P.C., Weber A.P., Wellesley D.G., Westwood P., White H., Parker M., Williams D., Jenkins L., Scott R.H., Kilby M.D., Chitty L.S., Hurles M.E., Maher E.R., Bateman M., Campbell C., Campbell J., Carey G., Cohen K., Collingwood E., Constantinou P., Delmege C., Ellis R., Evans J., Everett T., Pinto C.F., Forrester N., Fowler E., Hamilton S., Healey K., Hudson R., Lester T., Lewis R., Marton T., Mehta S., Park S. M., Rowland J., Steer J., Taylor E.J., Wilson E. Prenatal Exome Sequencing Analysis in Fetal Structural Anomalies Detected by Ultrasonography (PAGE): A Cohort Study. Lancet. 2019; 393 (10173): 747–757. https://doi.org/10.1016/S0140-6736(18)31940-8Калашникова Е. А., Глотов А. С., Андреева Е. Н., Барков И. Ю., Бобровник Г. Ю., Дубровина Е. В., Жученко Л. А. Cовременное значение неинвазивного пренатального исследования внеклеточной ДНК плода в крови матери и перспективы его применения в системе массового скрининга беременных в Российской Федерации. Журнал акушерства и женских болезней. 2021; 70 (1): 19–50. https://doi.org/10.17816/JOWD56573Kalashnikova E.A., Glotov A.S., Andreyeva E.N., Barkov I. Yu., Bobrovnik G.Yu., Dubrovina E.V., Zhuchenko L.A. Current relevance of non-invasive prenatal study of cell-free fetal DNA in the mother’s blood and prospects for its application in mass screening of pregnant women in the Russian Federation. Journal Akusherstva I Zhenskih bolezney. = Journal of Obstetrics and Women’s Diseases. 2021; 70 (1): 19–50. https://doi.org/10.17816/JOWD56573 (In Russian)The Fetal Medicine Foundation. The 11–13 Weeks Scan. Internet-Based Course. https://courses. fetalmedicine.comThe Fetal Medicine Foundation. The 11–13 Weeks Scan. Internet-Based Course. https://courses. fetalmedicine.comПриказ Департамента здравоохранения города Москвы от 13.03.2020 № 199 “Об организации проведения неинвазивного пренатального теста в городе Москве”. 2020.Order of the Department of Health of the city of Moscow dated 10.20.2020 No. 119 “On Organization of Providing Non-invasive prenatal testing in the city of Moscow”. 2020. (In Russian)

The authors declare that there are no conflicts of interest present.